ETRA

8.2807.38%
CW

Christopher William Clark

Chief Financial Officer

Mr. Christopher William Clark, CFA, also known as Chris, serves as Chief Financial Officer of Electra Therapeutics, Inc. since August 2026 and was its Executive Vice President of Strategy & Finance from December 2025 to August 2026. He was a Portfolio Manager at RS Investment Management Co. LLC and had been an Analyst in its Growth team since joining RS Investment in May 2007. Mr. Clark served as Portfolio Manager at Victory Capital Management Inc. Previously, he served as a Research Associate at TIAA-CREF for three years. He focused on global portfolio management and the health care sector at the firm. Prior to that, Mr. Clark served as a Research Assistant at Dresdner RCM Global Investors for three years. He began his investment career in 2001. Mr. Clark is a Chartered Financial Analyst. He holds a B.A. in Economics from the University of Virginia.

Positions